Company intelligence / Profile preview

Sofinnova Ventures

Menlo Park, California, United States

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Sofinnova Ventures (now Sofinnova Investments in the US) is one of the most established venture capital firms in biotech, healthcare, and life sciences. It predominantly invests in innovative therapeutics, platforms, and devices at both the early and clinical stages, having supported companies to market and beyond. As a VC, it does not have its own clinical results, but its portfolio companies include a large number of successful clinical-stage and commercial products.[4][5][6][8][11][12]

Modalities: Small moleculeGene therapyMonoclonal antibodyAntibody-drug conjugateBiologicProteinRNA therapyCell therapyDevicemRNA-based drugsEnzyme replacement therapy
Industry: Investors

Partnerships

AmgenBristol Myers SquibbPfizer Ventures

Beyond the preview

Go deeper on Sofinnova Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sofinnova Ventures.

Explore the full profile